Supreme Court bars patents on human genes
The Supreme Court ruled unanimously that human genes are a “product of nature” and therefore may not be patented.
The Supreme Court last week ruled unanimously that human genes are a “product of nature” and therefore may not be patented. The ruling quashed patents held by pharmaceutical company Myriad Genetics on two genes linked to breast and ovarian cancer. Myriad argued they had “isolated” the genes by spending millions of dollars on research. Justice Clarence Thomas stated that “naturally occurring DNA” may not be treated in the same way as “human-made” inventions. Myriad had been the only company legally able to perform expensive tests for hereditary breast and ovarian cancers. Within hours of the ruling, several other companies announced plans to offer testing for the genes.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
What are the rules of a no-buy vs. low-buy year?
The Explainer These two revised approaches to purchasing could help you save big
By Becca Stanek, The Week US Published
-
80 dead in Colombia amid uptick in guerrilla fighting
Speed Read This was the country's deadliest wave of violence since the peace accords set by President Gustavo Petro in 2016
By Peter Weber, The Week US Published
-
Trump starts term with spate of executive orders
Speed Read The president is rolling back many of Joe Biden's climate and immigration policies
By Peter Weber, The Week US Published